Small molecule-dependent inteins and uses thereof

Abstract

Elucidating the function of proteins in mammalian cells is particularly challenging due to the inherent complexity of these systems. Methods to study protein function in living cells ideally perturb the activity of only the protein of interest but otherwise maintain the natural state of the host cell or organism. Ligand-dependent inteins offer single-protein specificity and other desirable features as an approach to control protein function in cells post-translationally. Some aspects of this invention provide second-generation ligand-dependent inteins that splice to substantially higher yields and with faster kinetics in the presence of the cell-permeable small molecule 4-HT, especially at 37° C., while exhibiting comparable or improved low levels of back-ground splicing in the absence of 4-HT, as compared to the parental inteins. These improvements were observed in four protein contexts tested in mammalian cells at 37° C., as well as in yeast cells assayed at 30° C. or 37° C. The newly evolved inteins described herein are therefore promising tools as conditional modulators of protein structure and function in yeast and mammalian cells.

Description

RELATED APPLICATION[0001]This application claims priority under 35 U.S.C. §119(e) to U.S. provisional patent application, U.S. Ser. No. 61 / 452,020, filed Mar. 12, 2011, entitled “Small Molecule-Dependent Inteins and Uses Thereof,” the entire contents of which are incorporated herein by reference.GOVERNMENT SUPPORT[0002]This invention was made with U.S. Government support under grant R01 GM065400, awarded by the National Institutes of Health (NIH), and grant HR0011-08-1-0085, awarded by the Defense Advanced Research Projects Agency (DARPA). The U.S. government has certain rights in this invention.BACKGROUND OF THE INVENTION[0003]Methods to control protein structure and function inside living cells have proven to be valuable tools to elucidate the roles of proteins in their native biological contexts (Schreiber, 2003; Buskirk and Liu, 2005; Banaszynski and Wandless, 2006). Traditional genetic methods that have been widely used to control protein function by altering expression levels ...

AI Technical Summary

Benefits of technology

This patent describes the development of improved intein variants that can splice efficiently and quickly in mammalian cells, such as humans. These new inteins are optimized for use at temperatures between about 30°C and 42°C and can be triggered by small molecules to control protein function in living systems. The second-generation inteins described herein exhibit significantly improved splicing activity and speed compared to the parental inteins and can be used as effective tools for small-molecule-triggered, post-translational modulation of protein activities in mammalian cells.

Problems solved by technology

These methods are highly specific to the protein of interest and can be applied to many proteins, but typically require days to reach steady-state protein levels in mammalian cells, are irreversible in the case of recombination-based methods, and are vulnerable to transcriptional compensation (Shogren-Knaak et al., 2001; Marschang et al., 2004; Wong and Roth, 2005; Acar et al., 2010).

No natural inteins, however, have been shown to be regulated by small molecules.

However, conventional ligand-dependent inteins were developed for use at room temperature and exhibit poor splicing efficiency or high background splicing in the absence of ligand when incubated at higher temperatures.

These characteristics limit the application of ligand-dependent inteins in mammalian cells.

Images